Program:
Start Year:
2021
Why did you choose Duke for your residency training?
As a Duke medical student, I believe the department has been so formative in shaping my career goals and modeling high-quality care across the reproductive spectrum. I have felt so well-supported throughout my time here by mentors who care not only about my professional but also my personal development. I have been impressed by the dedication to advocacy, research and education at Duke, as well as the strong bonds and friendships the residents have with each other and the faculty and staff.
What excites you about the residency program at Duke OB/GYN?
I'm excited to work and hang with my co-residents, be inspired and mentored by leaders in the field, and most importantly, learn how to care for and empower the women of Durham.
What are your career goals?
I hope to provide compassionate, evidence-based care and to advocate for the women I serve. I am interested in a career in academic medicine.
Describe your research interests/goals:
Health services research, including access to care, health policy and improving quality care.
What are your hobbies?
All things F&B, reading good fiction and practicing yoga when I can
Education & Training
Undergraduate school & graduation year:
Yale College, 2015
Medical school & graduation year:
Duke University School of Medicine, 2021
Publications
Wu, J., Logue, T., Kaplan, S. J., Tergas, A. I., Melamed, A., Khoury-Collado, F., … & Wright, J.D.. (2020, Aug). Less-Radical Surgery in Early Stage Cervical Cancer: A Systematic Review. American Journal of Obstetrics & Gynecology, 224(4):348-358. PMID: 33306971.
Wu, J., Huang, Y., Tergas, A.I., Melamed, A., Khoury-Collado, F., Hou, J.Y., St Clair, C.M., Ananth, C.V., Hershman, D.L., & Wright, J.D.. (2020, Aug). The Effect of Guideline-Concordant Care in Mitigating Insurance Status Disparities in Cervical Cancer. Gynecologic Oncology, 159(2), 309-316. PMID: 32800656.
Wu, J., Denoble, A. E., Kuller, J. A., & Dotters-Katz, S. K. (2021, Nov). Management of Cerclage in Patients with Preterm Prelabor Rupture of Membranes. Obstetrical & Gynecological Survey, 76(11):681-691. PMID: 34854925.
Moss, H.A., Wu, J., Kaplan, S.J., & Zafar, S.Y.. (2020, Aug). The Affordable Care Act’s Medicaid Expansion and Impact Along the Cancer-Care Continuum: A Systematic Review. Journal of the National Cancer Institute, 112(8), 779-791. PMID: 32277814.
Dioun S., Wu, J., Chen, L., Kaplan, S., Huang, Y., Melamed, A., … & Wright, J.D. (2021, Aug). Intraoperative Rupture of the Ovarian Capsule in Early-Stage Ovarian Cancer: A Meta-analysis. Obstetrics & Gynecology, 138(2)-261-271. PMID: 34237756.
Denoble A.E., Wu, J., Mitchell, C.J., Hughes, B.L., & Dotters-Katz, S.K.. (2020, Jul). Chorioamnionitis versus Intraamniotic Infection Among Preterm Deliveries - is postpartum infectious morbidity different? American Journal of Obstetrics & Gynecology MFM, 2(3), 100176. PMID: 33345890.
Knisely, A.,* Zhou, Z.,* Wu, J.,* Huang, Y., Holcomb, K., Melamed, A., … & Wright, J.D.. (2021, Jan). Perioperative Morbidity and Mortality of Patients with COVID-19 who Undergo Urgent and Emergent Surgical Procedures. Annals of Surgery, 273(1):34-40. PMID: 33074900.
Knisely, A.,* Wu, J.,* Kaplan, S. J., Zhou, Z.N., Melamed, A., Tergas, A.I., St. Clair, C. M., Hou, J.Y., Khoury-Collado, F., Huang, Y.Y., Hershman, D.L., & Wright, J.D.. (2020, Sep). Coronavirus Spectrum Infections (COVID-19, MERS, SARS) in Cancer Patients: A Systematic Review of the Literature. Cancer Investigations, 38(8-9), 436-444. PMID: 32787597.
Huang, A., Wu, J., Chen, L., Albright, B.B., Previs, R.A., Moss, H.A., … & Wright, J.D. (2021, Nov). Neoadjuvant chemotherapy for advanced endometrial cancer: A systematic review. Gynecologic Oncology Reports, 38:100887. PMID: 34820496.
Tsai, S., Chung, E.H., Truong, T., Farrell, A.S., Wu, J., Ohamadike, O., & Eaton, J.L. (2022, Mar). Racial and ethnic disparities among donor oocyte banks in the United States. Fertility and Sterility, 117(3):622-628. PMID: 35058045
Lee, J.W., Zhang, Y., Eoh, K.J, Sharma, R., Sanmamed, M.F., Wu, J., … & Koo, J. S. (2019, Jun). The combination of MEK inhibitor with immunomodulatory antibodies targeting programmed death 1 and programmed death ligand 1 results in prolonged survival in Kras/p53-driven lung cancer. Journal of Thoracic Oncology, 14(6), 1046-1060. PMID: 30771521.
Presentations & Posters
Wu, J., Montes de Oca, M.K., Strickland, K., & Previs, R.A. Threshold of tumor mutational burden and association with survival in ovarian cancer. Mid-Atlantic Gynecologic Oncology Society Annual Conference. (October 22, 2021). Virtual presentation.
Wu, J., Montes de Oca, M.K., Strickland, K., & Previs, R.A. Threshold of tumor mutational burden and association with survival in ovarian cancer. Society of Gynecology Oncology 2022 Annual Meeting. (March 18-21, 2022). Virtual poster.
Wu, J., Trahair, E.D., Happ, M., & Swartz, J.J. TikTok and #IUD: the user experience with intrauterine devices on social media. 2022 Society of Family Planning Annual Meeting. (December 3-5, 2022). Poster presentation.